<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Acorda Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Acorda Therapeutics, Inc.

    Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cohen, MD
    • FOUNDED
      1995
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Akero Therapeutics, Inc.

    Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high...

    Akero aims to develop and deliver transformatio...

    Filing Type:    PU
    Vericel Corporation

    Vericel Corporation

    Vericel is a leader in advanced therapies for the sports medicine and severe burn ...

    Vericel is a leader in advanced therapies for t...

    Filing Type:    PU
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    Calithera Biosciences, Inc.

    Calithera Biosciences, Inc.

    Calithera is a clinical-stage biopharmaceutical company pioneering the discovery a...

    Calithera is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    Neurocarrus Inc

    Neurocarrus Inc

    Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...

    Neurocarrus is developing a breakthrough therap...

    Amount Raised:    $344,168.00
    Fundraising Status:    EC
    Filing Type:    CF
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.